Drugs

News and Updates about the regulations in Drugs and Pharma

HCG Collaborates with Trucan Diagnostics for Cancer Treatment Monitoring and Response Prediction

India’s leading cancer care provider, HealthCare Global Enterprises (HCG), has unveiled a research initiative in partnership with the innovative startup, Trucan Diagnostics Pvt Ltd, known for its cutting-edge cancer diagnostics. The goal of this collaboration is to authenticate a range […]

HCG Collaborates with Trucan Diagnostics for Cancer Treatment Monitoring and Response Prediction Read More »

India Captures 8% of Global Medical Tourism Market with Leading Expertise and Quality Care

India’s medical tourism industry is rapidly expanding, establishing the nation as a premier global hub for cost-effective and superior healthcare solutions. The country’s reputation is bolstered by healthcare facilities like PSRI Hospital, which excel in patient-focused, clinical care, affirming India’s

India Captures 8% of Global Medical Tourism Market with Leading Expertise and Quality Care Read More »

Telangana Declares Itself a Global Life Sciences Leader with Over Rs. 36,000 Crore in Investments, Resulting in 51,000 Jobs

The Telangana government has proudly reported remarkable strides in the life sciences domain, amassing investments exceeding Rs. 36,000 crore across more than 140 projects within the past year. These investments are projected to generate 51,000 direct employment opportunities and approximately

Telangana Declares Itself a Global Life Sciences Leader with Over Rs. 36,000 Crore in Investments, Resulting in 51,000 Jobs Read More »

Anixa Biosciences Advances Patient Treatment in Third Group for Phase 1 CAR-T Therapy Trial in Recurrent Ovarian Cancer

Anixa Biosciences, Inc. (Anixa), a biotech firm dedicated to cancer treatment and prevention, revealed its initiation of patient treatment in the third cohort of its ongoing Phase 1 clinical trial. This trial explores their innovative chimeric antigen receptor-T cell (CAR-T)

Anixa Biosciences Advances Patient Treatment in Third Group for Phase 1 CAR-T Therapy Trial in Recurrent Ovarian Cancer Read More »

Cytokinetics and Bayer Partner for Aficamten Development and Commercialization in Japan

Cytokinetics, a specialty biopharmaceutical company focusing on cardiovascular diseases in advanced stages, has joined forces with Bayer through an exclusive collaboration and licensing arrangement. This partnership aims to advance the development and marketing of aficamten for patients in Japan suffering

Cytokinetics and Bayer Partner for Aficamten Development and Commercialization in Japan Read More »

Abbott’s Amplatzer Amulet Device Shows Long-Term Advantages for AFib Patients Prone to Stroke

Abbott, a leader in the healthcare sector, revealed significant new findings concerning its Amplatzer Amulet Left Atrial Appendage (LAA) Occluder for individuals with atrial fibrillation (AFib) who face heightened stroke risk. Recent five-year research highlights that patients using Abbott’s Amplatzer

Abbott’s Amplatzer Amulet Device Shows Long-Term Advantages for AFib Patients Prone to Stroke Read More »